Evidence map›Paper›PMID 41958997›Full record

ArticlebioRxiv : the preprint server for biology2026

Comparative single-cell atlases reveal injury-driven tubal epithelial regeneration as a window for ovarian carcinoma initiation.

Coulter Q Ralston, Andrea Flesken-Nikitin, Dah-Jiun Fu, Christopher S Ashe, Blaine A Harlan, Md Mozammal Hossain, Derek K Wang, Anna Yemelyanova, Elisa Schmoeckel, Andrew K Godwin and 3 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Coulter Q RalstonDepartment of Biomedical and Translational Sciences, New York, New York, USA.ORCID 0000-0003-2093-6482
Andrea Flesken-NikitinDepartment of Biomedical and Translational Sciences, New York, New York, USA.ORCID 0000-0003-3017-1399
Dah-Jiun FuDepartment of Biomedical and Translational Sciences, New York, New York, USA.ORCID 0000-0001-5854-181X
Christopher S AsheDepartment of Biomedical and Translational Sciences, New York, New York, USA.ORCID 0009-0003-2460-7464
Blaine A HarlanDepartment of Biomedical and Translational Sciences, New York, New York, USA.ORCID 0000-0002-5559-3881
Md Mozammal HossainDepartment of Biomedical and Translational Sciences, New York, New York, USA.
Derek K WangDepartment of Biomedical and Translational Sciences, New York, New York, USA.
Anna YemelyanovaDepartment of Pathology & Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.ORCID 0009-0008-3227-1696
Elisa SchmoeckelInstitute of Pathology, Ludwig Maximilians University, Munich, Germany.ORCID 0000-0001-7199-3837
Andrew K GodwinDepartment of Pathology & Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.ORCID 0000-0002-3987-9580
Doris MayrInstitute of Pathology, Ludwig Maximilians University, Munich, Germany.
Benjamin D CosgroveMeinig School of Biomedical Engineering, New York, New York, USA.ORCID 0000-0003-2164-350X
Alexander Yu NikitinDepartment of Biomedical and Translational Sciences, New York, New York, USA.ORCID 0000-0002-3729-7982

Funding

Transgenic & Gene-Targeting Shared ResourceP30CA168524 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ROY A. JENSEN · 2012 to 2026
$40.1M
Using Integrated Omics to Identify Dysfunctional Genetic Mechanisms Influencing Schizophrenia and Sleep DisturbancesP20GM130423 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Diane E Mahoney · 2019 to 2026
$21.5M
JHU-Mayo-NIA Murine Senescence Mapping Program (JMN-MSMP)U54AG079779 · NIA · JOHNS HOPKINS UNIVERSITY · PI JENNIFER H ELISSEEFF · 2022 to 2026
$6.4M
Endometrial epithelial stem cells and cancerR01CA248524 · NCI · CORNELL UNIVERSITY · PI NIKITIN, ALEXANDER Y. · 2021 to 2025
$2.1M
Cancer-prone cell states of the fallopian tubal epitheliumR01CA260115 · NCI · CORNELL UNIVERSITY · PI NIKITIN, ALEXANDER Y. · 2021 to 2025
$2.1M
Origins of Ovarian CarcinomaR01CA182413 · NCI · CORNELL UNIVERSITY · PI NIKITIN, ALEXANDER Y. · 2015 to 2019
$1.8M
Zeiss LSM710 Confocal Microscope for Shared Imaging FacilityS10RR025502 · NCRR · CORNELL UNIVERSITY · PI WILLIAMS, REBECCA M · 2009 to 2009
$500k
NCI NIH HHS P30 CA168524NCI NIH HHS R01 CA182413NCI NIH HHS R01 CA248524NCI NIH HHS R01 CA260115NCRR NIH HHS S10 RR025502NIA NIH HHS U54 AG079779NIGMS NIH HHS P20 GM130423
6 · The paper itself

Abstract

High-grade serous carcinoma (HGSC), the most lethal form of ovarian cancer, preferentially originates in the tubal epithelium (TE) of the distal uterine tube (also known as Fallopian tube or oviduct). Mouse models are widely used to study how HGSC initiates in humans; however, the extent to which mouse and human uterine tubes are comparable remains unclear. Here, we conduct cross-species single-cell transcriptomic comparative analyses and organoid assay validations to reveal conserved differentiation trajectories from bipotent progenitors to secretory or ciliated cell fates. Regional analyses of both datasets reveal enriched injury repair features in the distal human TE, where mice lack such a trend. Experimentally inducing mechanical injury to the mouse TE yields significant expansion of pre-ciliated cells compared to uninjured counterparts. Furthermore, inactivation of

Identifiers

PMID41958997
PMCPMC13060286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.